Related Experiment Video
Updated: Jul 12, 2025

13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.2K
Hepatitis C Virus Elimination Program among Prison Inmates, Israel
Emerging Infectious Diseases
|October 25, 2023
Summary
An Israeli prison program successfully reduced hepatitis C virus (HCV) burden by offering testing and antiviral therapy to high-risk inmates. The initiative identified and treated HCV infections, improving health outcomes for incarcerated individuals.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Hepatology
Background:
- Hepatitis C virus (HCV) poses a significant health challenge within correctional facilities.
- Early detection and treatment are crucial for HCV elimination efforts.
Purpose of the Study:
- To evaluate the effectiveness of an HCV elimination program implemented in Israeli prisons.
- To assess the prevalence of HCV RNA among high-risk incarcerated individuals and the impact of antiviral therapy.
Main Methods:
- The Israeli Prison Services initiated an HCV screening program in 2020.
- High-risk inmates underwent serology testing, followed by HCV RNA testing for seropositive individuals.
- Participants with detectable HCV RNA were offered antiviral drug therapy.
Main Results:
- The program identified a 7.0% prevalence of detectable HCV RNA among participants.
- Incarcerated individuals with confirmed HCV infections were provided with antiviral treatment.
Conclusions:
- The implemented HCV elimination program effectively reduced the HCV burden among the incarcerated population.
- Targeted screening and treatment strategies are vital for controlling viral hepatitis in prisons.

